PBD-C06

N/A

Report date: 2024/01/09 14:13:00

Base Information

Drug NamePBD-C06
Drug Alias Nameanti-pGlu3-Abeta monoclonal antibody (Vivoryon Therapeutics)PBD-C06SIM-0409
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAmyloid beta-protein precursor inhibitors
TargetsAmyloid beta-protein precursor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivoryon Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesVivoryon Therapeutics AgSimcere Pharmaceutical Group Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A